Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AMPK
    (3)
  • Amino Acids and Derivatives
    (3)
  • Antibacterial
    (3)
  • Antioxidant
    (3)
  • Apoptosis
    (3)
  • Autophagy
    (3)
  • DNA/RNA Synthesis
    (2)
  • Endogenous Metabolite
    (37)
  • Neuropeptide Y Receptor
    (3)
  • Others
    (100)
TargetMol | Tags By ResearchField
  • Cardiovascular disease
    (1)
  • Metabolic diseases
    (5)
  • Neurological disorders
    (1)
  • Tumor/Cancer
    (7)
Filter
Search Result
Results for "

energy

" in TargetMol Product Catalog
  • Inhibitor Products
    146
    TargetMol | Activity
  • Recombinant Protein
    61
    TargetMol | inventory
  • Natural Products
    58
    TargetMol | natural
  • Compound Libraries
    20
    TargetMol | composition
  • Peptides Products
    19
    TargetMol | Activity
  • Dye Reagents
    12
    TargetMol | inventory
  • Isotope products
    5
    TargetMol | natural
  • PROTAC Products
    1
    TargetMol | composition
Human Endogenous Metabolite Compound Library Plus
L2501
A unique collection of 1283 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.
  • $20,280
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Anti-Cancer Compound Library
L2100
A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
  • $94,750
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Mitochondria-Targeted Compound Library
L5300
A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;
  • $26,120
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Anti-Obesity Compound Library
L7100
A unique collection of 2247 anti-obesity compounds for high throughput and high content screening;
  • $57,860
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Flavonoid Natural Product Library
L6120
A unique collection of 514 flavonoids can be used for high throughput and high content screening;
  • $14,810
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Anti-Cancer Metabolism Compound Library
L2130
A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
  • $27,040
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Kinase Inhibitor Library
L1600
A unique collection of 2720 kinase inhibitors regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;
  • $54,920
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Lipid Metabolism Compound Library
L2510
A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
  • $12,100
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Anti-Cancer Active Compound Library
L2160
A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
  • $56,480
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
PI3K-AKT-mTOR Compound Library
L1300
A unique collection of 420 compounds targeting PI3K Akt mTOR signaling for research in PI3K Akt mTOR signaling, and drug discovery in diseases involved with PI3K Akt mTOR signaling;
  • $17,100
Backorder
Size
QTY
TargetMol | Citations Cited
FDA-Approved Kinase Inhibitor Library
L1610
A unique collection of 263 kinase inhibitors regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.
  • $7,390
Backorder
Size
QTY
TargetMol | Citations Cited
Nuclear Receptor Compound Library
L1510
A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;
  • $12,160
Backorder
Size
QTY
TargetMol | Citations Cited
Anti-Cancer Approved Drug Library
L2110
A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
  • $31,940
Backorder
Size
QTY
TargetMol | Citations Cited
Glutamine Metabolism Compound Library
L2550
A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;
  • $17,050
Backorder
Size
QTY
TargetMol | Citations Cited
AMPK-Targeted Compound Library
L1120
80 well-chosen unique AMPK-targeted small molecules;
  • $2,260
Backorder
Size
QTY
TargetMol | Citations Cited
Anti-Cancer Clinical Compound Library
L2120
A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);
  • $45,870
Backorder
Size
QTY
TargetMol | Citations Cited
HIF-1 Signaling Pathway Compound Library
L8500
A unique collection of 1336 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies;
  • $28,410
Backorder
Size
QTY
TargetMol | Citations Cited
Anti-Cancer Drug Library
L2150
A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
  • $55,460
Backorder
Size
QTY
TargetMol | Citations Cited
Anti-Cancer Compound Library Plus
L2180
Well-chosen 1468 anti-tumor compounds with unique structures;
  • $36,250
Backorder
Size
QTY
TargetMol | Citations Cited
Histamine & Melatonin Receptor-Targeted Compound Library
L3300
A unique collection of 153 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs;
  • $4,180
Backorder
Size
QTY
TargetMol | Citations Cited